Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Net Debt Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual net debt in 2023 was -1.94 Million TWD , down -116.93% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly net debt in 2024 Q1 was -124.58 Million TWD , down -6305.4% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported annual net debt of 11.48 Million TWD in 2022, up 2188.55% from previous year.
  • Mercury Biopharmaceutical Corporation reported annual net debt of -550 Thousand TWD in 2021, down -357.01% from previous year.
  • Mercury Biopharmaceutical Corporation reported quarterly net debt of -124.49 Million TWD for 2024 Q2, up 0.36% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported quarterly net debt of -2.62 Million TWD for 2023 Q3, up 93.42% from previous quarter.

Annual Net Debt Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Net Debt of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -1.94 Million TWD -116.93%
2022 11.48 Million TWD 2188.55%
2021 -550 Thousand TWD -357.01%
2020 214 Thousand TWD 7233.33%
2019 -3000.00 TWD 0.0%

Peer Net Debt Comparison of Mercury Biopharmaceutical Corporation

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD 101.092%
GeneFerm Biotechnology Co., Ltd. 31.92 Million TWD 106.092%
Easywell Biomedicals, Inc. 123.43 Million TWD 101.576%
TTY Biopharm Company Limited -705.97 Million TWD 99.724%
Synmosa Biopharma Corporation 1.52 Billion TWD 100.128%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 100.063%
Center Laboratories, Inc. 3.91 Billion TWD 100.05%
Tien Liang BioTech Co., Ltd. -57.55 Million TWD 96.621%
Orient Pharma Co., Ltd. 633.6 Million TWD 100.307%
InnoPharmax Inc. -17.85 Million TWD 89.109%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 99.79%
Excelsior Biopharma Inc. -212.51 Million TWD 99.085%
DV Biomed Co., Ltd. 160.7 Million TWD 101.21%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 99.751%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 99.703%
UniPharma Co., Ltd. -68.36 Million TWD 97.155%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD 100.395%
Alar Pharmaceuticals Inc. -738.05 Million TWD 99.736%
Winston Medical Supply Co., Ltd. -191.81 Million TWD 98.986%
Bioray Biotech Co., Ltd -27.23 Million TWD 92.858%
TSH Biopharm Corporation Limited -568.74 Million TWD 99.658%